Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) – Global Forecasts to 2026

2021-07-14
Price :
Published : Jul-2021
No. of Pages : 204
Inquire before Buying request discount

“Growing incidence of preventable chronic diseases and the need to control healthcare costs are the key factors driving the growth of the digital therapeutics market.”

The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4%. Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics. However, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.

Treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2020

Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications. The large share of this segment is attributed to the growing incidences of chronic diseases, the rising economic burden of their treatment, and investments in digital therapeutics to encourage the development of cost-effective and scalable treatment platforms for these conditions.

Diabetes segment is expected to dominate the market

Based on the type of treatment/care-related application, the digital therapeutics market is further segmented into diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence, gastrointestinal disorders, substance use disorders & addiction management, rehabilitation & patient care, and other treatment/care-related applications. Diabetes commanded the largest share of 19.0% of the digital therapeutics market for treatment/care-related applications in 2020. The growing prevalence of diabetes, high healthcare costs associated with diabetes, and increasing government initiatives to reduce the burden with the help of cost-effective solutions are expected to drive the market growth in this segment.

B2B segment is expected to grow at the highest CAGR during the forecast period.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). This is attributed to growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the inclination of pharmaceutical companies to integrate digital therapeutics with their drug products.

North America to be the largest and the fastest-growing regional market

North America, which comprises the US and Canada, forms the largest market for digital therapeutics. Factors such as the influx of new startups, increasing investments in digital therapeutics, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements drive market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (50%), Tier 2 (30%), and Tier 3 (20%)
  • By Designation: C-level (75%), D-level (15%), and Others (10%)
  • By Region: North America (70%), Europe (20%), APAC (7%), and the RoW(3%)

List of Companies Profiled in the Report

  • Noom (US)
  • Livongo Health (US)
  • Omada Health (US)
  • WellDoc (US)
  • Pear Therapeutics (US)
  • Proteus Digital Health (US)
  • Propeller Health (US)
  • Akili Interactive Labs (US)
  • Better Therapeutics (US)
  • Happify (US)
  • Kaia Health (Germany)
  • Mango Health (US)
  • Click Therapeutics (US)
  • Canary Health (US)
  • Wellthy Therapeutics (India)
  • Cognoa (US)
  • Ayogo Health (Canada)
  • Mindstrong Health (US)
  • 2Morrow (US)
  • Ginger (US)
  • BehaVR Inc., (US)
  • Mindable Health (Germany)
  • Virta Health (US)
  • Hinge Health (US)
  • Doktor.se (Sweden)

Research Coverage:

This report provides a study of the digital therapeutics market. It aims at estimating the size and future growth potential of the market across different segments, such as sales channel, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall digital therapeutics market and its sub segments. This report will also help stakeholders understand the competitive landscape, gain insights to position their business,and make suitable go-to-market strategies. It will also enable stakeholders to gauge the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

Filed in: Technology
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Artificial Intelligence (AI) in Drug Discovery Market by Offering (Software, Service), Technology (Machine Learning, Deep Learning), Application (Cardiovascular, Metabolic, Neurodegenerative), End User (Pharma, Biotech,CROs) – Global Forecasts (2022 – 2027)

“Artificial Intelligence/AI in Drug Discovery Market to register a CAGR of 45.7% from 2022 to 2027” The Artificial intelligence/AI in drug discovery Market is projected to reach USD 4.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 45.7% during the forecast period. The growth of this market is primarily driven by factors such as the need to control drug discovery & development costs and reduce the overall time taken in this process, the rising adoption of cloud-based applications and services. On the other hand, the inadequate availability of skilled labor is key factor restraining the market growt at certain extent over the forecast period. . “Services segment is estimated to hold the major share in 2022 and also expected to grow at the highest over the foreca......
 $4950

Operating Room/OR Integration Market by Component (Hardware, Software, Service), Application (General, Orthopedic, & Cardiovascular Surgery), Device (Audio & Video Management, Display, Document Management), End User (Hospital, ASC) – Global Forecast to 2027

“The operating room integration market is projected to grow at a CAGR of 12.1% between 2022 and 2027.” The global operating room integration market is projected to reach USD USD 3.3 billion by 2027 from an estimated USD 1.9 billion in 2022, at a CAGR of 12.1% during the forecast period. Growth in this market is driven by the rising demand for technologically advanced healthcare solutions, the growing number of surgical procedures worldwide, rising funding initiatives to improve HCIT infrastructure, and increasing emphasis on cost control in hospitals. However, the high setup and operational costs is expected to restrain market growth to a certain extent during the forecast period. “Services was the fastest-growing segment in the type of operating room integration market in 2021......
 $4950

Patient Experience Technology Market by Component (Technology (Patient Rounding, Patient experience survey), Consulting Services) & Facility Type (Acute Care, Post Acute Care, Non Acute Care (Physicians Office, Clinics)) – US Forecasts to 2026

“US patient experience technology market to register a CAGR of 10.7% from 2021 to 2026” The US patient experience technology market is projected to reach USD 299 million by 2026 from USD 179 million in 2021, at a CAGR of 10.7% during the forecast period. Growth in this market is driven by factors such as the favorable government regulations and initiatives to promote the adoption of HCIT solutions, the advantages of patient rounding solutions, and the growing number of collaborations and partnerships between stakeholders. However, factors such as the high investments for IT infrastructure and the shortage of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market to a certain extent during the forecast period. “Technology segmen......
 $4950

Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantic), End User (Hospitals, Pharmacies, Clinics, Payers) – Global Forecast to 2026

“The healthcare interoperability solutions market is projected to grow at a CAGR of 13.9% between 2021 and 2026.” The global healthcare interoperability solutions market is projected to reach USD 5.7 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 13.9% during the forecast period. Growth in this market is driven by the growing need to curtail healthcare costs, government initiatives to enhance patient care & safety, government funding for healthcare interoperability, and the rapid adoption of EHR & other healthcare IT solutions. However, the lack of true interoperability solutions, lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the fore......
 $4950

Healthcare IT Integration Market by Product (Interface Engine, Medical Device Integration, Media Integration), Service (Integration, Maintenance, Training, Consulting), End User (Hospital, Laboratories, Home Healthcare, Clinic) – Global Forecast to 2026

“The healthcare IT integration market is projected to grow at a CAGR of 12.4% during the forecast period (2021–2026).” The global healthcare IT integration market is projected to reach USD 7.1 billion by 2026 from USD 3.9 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth in the healthcare IT integration market is mainly driven primarily by the increased use of connected care technologies during COVID-19, rapid adoption of electronic health records and other healthcare IT solutions, urgent need to integrate patient data into healthcare systems and favourable government policies, funding programs, and initiatives to deploy healthcare IT integration solutions. On the other hand, the interoperability issues and the high cost associated with healthcare IT integ......
 $4950

Healthcare Fraud Analytics Market by Solution Type (Descriptive, Predictive, Prescriptive), Application (Insurance Claim, Payment Integrity), Delivery (On-premise, Cloud), End User (Government, Employers, Payers), COVID-19 Impac – Global Forecast to 2026

The healthcare fraud analytics market is expected to grow at a CAGR of 26.7% in the forecast period. The global healthcare fraud analytics market is projected to reach USD 5.0 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 26.7% during the forecast period. Market growth can be attributed to a large number of fraudulent activities in healthcare, increasing number of patients seeking health insurance, high returns on investment, and the rising number of pharmacy claims-related frauds. However, the dearth of skilled personnel is expected to restrain the growth of this market. The on-demand segment is expected to grow at the highest CAGR during the forecast period On the basis of delivery model, the healthcare fraud analytics market is segmented into on-premise and on-dema......
 $5650

Laboratory Informatics Market by Type of Solutions (LIMS, ELN, CDS, EDC, CDMS, LES, ECM, SDMS), Component (Software, Service), Delivery (On premise, Cloud), Industry (CRO, CMO, Pharma, Biotech, Chemical, Agriculture, Oil, Gas) – Global Forecasts to 2026

Global laboratory informatics market projected to grow at CAGR of 10.8%” The global laboratory informatics market is estimated to reach USD 5.6 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 10.8% during the forecast period. The increasing need for laboratory automation; development of integrated lab informatics solutions; need to comply with regulatory requirements; and the growing demand in biobanks/biorepositories, academic research institutes, and CROs are the major factors driving the growth of the laboratory informatics market. On the other hand, lack of integration standards and high maintenance and service costs are expected to restrain the growth of this market in the coming years. LIMS segment is projected to record the highest CAGR Based on type of solutio......
 $5650

5G in Healthcare Market by Component (Hardware, Connectivity, Services) Application (Remote Patient Monitoring, Connected Medical Devices, AR/VR, Connected Ambulance, Asset Tracking) End User (Healthcare Providers, Payers) – Global Forecast to 2026

Increasing adoption of telehealth and robotics surgery due to COVID-19 are driving market growth” 5G stands for the fifth generation of mobile communication technology. With each generation’s new technology and standards, there have been improvements in transmission speed and network capacity. 5G represents a big leap in cellular technology and in healthcare by providing essential levels of connectivity to enable a new health ecosystem, one that can meet the needs of patients and providers accurately, efficiently, cost-effectively, conveniently, and at a substantial scale. This massive network will include billions of low-bitrates and low-energy connected health monitoring devices, remote sensors, and clinical wearables, with 5G providing a backbone infrastructure for IoT. The 5G......
 $5650

Revenue Cycle Management/RCM Market by Product & Services (Eligibility Verification, Clinical Coding, CDI, Claims Processing, Denial Management, Outsourcing Services, Cloud), End User (Payers, Hospitals, Outpatient), Covid-19 Impact – Global Forecast to 2026

“The Revenue cycle management market is projected to grow at a CAGR of 10.6% during the forecast period (2020–2026).” The global revenue cycle management market is projected to reach USD 67.8 billion by 2026 from USD 40.9 billion in 2021, at a CAGR of 10.6% during the forecast period. The growth of this market is majorly attributed to the growing regulatory requirements & government initiatives to boost the adoption of RCM solutions, increasing patient volumes, and the growing need to manage unstructured healthcare data. However, the deployment of RCM software and the associated infrastructure requires significant investments, owing to which the adoption of RCM is low among small healthcare organizations. This, along with a dearth of skilled personnel, is expected to challenge......
 $5650

Speech and Voice Recognition Market with COVID-19 Impact Analysis by Delivery Method, Deployment Mode (On Cloud, On-Premises/Embedded), Technology (Speech Recognition, Voice Recognition), Vertical and Geography – Global Forecast to 2026

The speech and voice recognition market is expected to grow from USD 8.3 billion in 2021 to USD 22.0 billion by 2026; it is expected to grow at a CAGR of 21.6% during the forecast period. The major driving factors for the growth of the speech and voice recognition market include increase in use of smart appliance and use of artificial intelligence technology to boost accuracy of speech and voice recognition system. In terms of deployment mode on-premises to grow with the highest CAGR  from 2021 to 2026 The on-premises/embedded segment is expected to witness high growth owing to the recent advancement of speech and voice recognition as a multifactor authentication system in BFSI and other enterprise applications, where on-premises voice recognition is used for a high degree of consu......
 $5650
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy